Overview
Wegovy is a once-weekly injectable prescription medicine containing semaglutide, used alongside a reduced-calorie diet and increased physical activity for adults struggling with excess weight.
How It Works
Wegovy mimics the GLP-1 hormone, helping regulate appetite and fullness. By targeting brain receptors and slowing digestion, it supports reduced hunger and lower food intake, which helps with sustainable weight loss.
What to Expect
-
Weekly subcutaneous injection under medical supervision
-
Integration with lifestyle support—diet, movement and routine
-
Clinical studies show average weight loss of around 15–16 % over about 68 weeks for treated adults
Who It’s For
Adults who have found weight loss difficult through diet and exercise alone, and who are ready to engage with a medically supervised plan combining treatment and lifestyle changes for lasting results.
Important Considerations
This is a prescription treatment and not a standalone fix. For best results it should be paired with healthy eating, regular movement and consistent habits. Some side-effects may occur during adjustment, and suitability must be evaluated by a healthcare professional.